Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum

See also
Status	Clinical Trial	Phase
Completed	`NCT02400268` - Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by Enterobacteriaceae	Phase 3
Completed	`NCT03401242` - Prevalence of ESBL and CPE in French Nursing Homes
Not yet recruiting	`NCT03967301` - Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics	N/A
Completed	`NCT02795949` - Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae	Phase 3
Completed	`NCT00573235` - Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli
Recruiting	`NCT00404625` - Infections Caused by ESbL-Producing Enterobacteriaceae in Italy	N/A
Recruiting	`NCT03671967` - PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)	Phase 4
Enrolling by invitation	`NCT03924934` - Community-associated Highly-Resistant Enterobacterales
Completed	`NCT03477084` - Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities
Not yet recruiting	`NCT05632315` - PMT for MDRO Decolonization	Phase 2
Withdrawn	`NCT03527056` - Pilot Study Using Oral Capsule FMT to Decolonize GI CRE	Early Phase 1
Completed	`NCT00826670` - Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study	Phase 4
Not yet recruiting	`NCT04903886` - Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae
Completed	`NCT02482051` - Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood
Recruiting	`NCT00894036` - The Burden and Genetic Variability of Extended-Spectrum ß-Lactamase (ESBL) - Producing Pathogens in Swiss Children	N/A
Suspended	`NCT05355350` - PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections	Phase 4
Recruiting	`NCT05516433` - Effect of Imipenem and Meropenem on the Digestive Microbiota and the Emergence and Carriage of Multidrug-resistant Bacteria
Recruiting	`NCT02450942` - 18F-FDS PET/CT in Healthy Volunteers and Patients With Suspected Infection	Early Phase 1
Recruiting	`NCT05035342` - Fecal Transplantation to Eradicate Colonizing Emergent Superbugs	Phase 3
Not yet recruiting	`NCT03411590` - The Effect of Fortified Growing-up Milk on Growth and Micronutrient Status of Nigerian Toddlers	N/A

NCT number	NCT00573521
Study type	Observational
Source	University of Pittsburgh
Contact
Status	Completed
Phase
Start date	November 2007
Completion date	June 2017

Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms